Modeling Human Nonalcoholic Fatty Liver Disease (NAFLD) with an Organoids-on-a-Chip System
The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
Nonalcoholic fatty liver disease (NAFLD) is a common metabolic and progressive disease, which has emerged as a major cause of chronic liver disease worldwide. It is characterized by the process ranging from simple steatosis to nonalcoholic steatohepatitis. However, a deep understanding of NAFLD progression remains challenging due to the lack of proper in vitro human disease models. In this work, we proposed a new strategy to establish a human NAFLD model based on a human-induced pluripotent stem cell (hiPSC)-derived liver organoids-on-a-chip system. This system allows us to characterize the pathological features of NAFLD in liver organoids by exposure to free fatty acids (FFAs) in perfused three-dimensional (3D) cultures during a prolonged period. Upon FFA induction, liver organoids exhibited lipid droplet formation and triglyceride accumulation. Moreover, they showed upregulated expressions of lipid metabolism-associated genes, indicating the abnormal lipid metabolic process in NAFLD. The FFA-exposed organoids also showed reactive oxygen species (ROS) production and elevated expression of various inflammatory cytokine genes and fibrogenic markers. These alterations represented the typical biochemical characteristics of NAFLD progression, which may provide insight into the potential mechanisms underlying steatosis. The proposed human NAFLD-on-a-chip model combines stem cell organoids with organs-on-chips, which may provide a promising platform for extending their applications for disease studies and effective therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, the organoid could recapitulate several liver diseases, including fatty liver disease, cirrhosis, and monogenic metabolic diseases (Guan et al., 2017;Wang et al., 2020;Guan et al., 2021).”
From Fast formation and maturation enhancement of human liver organoids using a liver-organoid-on-a-chip (2024) · cites this paper as Wang et al., 2020
Citations
Cites
Cerebral organoids model human brain development and microcephaly
Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013) · Nature · doi:10.1038/nature12517 · Cited by 5,372
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Modeling Development and Disease with Organoids
Clevers, H. (2016) · Cell · doi:10.1016/j.cell.2016.05.082 · Cited by 3,196
Organogenesis in a dish: Modeling development and disease using organoid technologies
Lancaster, M. A., & Knoblich, J. A. (2014) · Science · doi:10.1126/science.1247125 · Cited by 2,931
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,679
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
Farrell, G. C., & Larter, C. Z. (2006) · Hepatology · doi:10.1002/hep.20973 · Cited by 2,414
Vascularized and functional human liver from an iPSC-derived organ bud transplant
Takebe, T., Sekine, K., Enomura, M., Koike, H., Kimura, M., Ogaeri, T., Zhang, R.-R., Ueno, Y., Zheng, Y.-W., Koike, N., et al. (2013) · Nature · doi:10.1038/nature12271 · Cited by 2,170
Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV Exposure
Qian, X., Nguyen, H. N., Song, M. M., Hadiono, C., Ogden, S. C., Hammack, C., Yao, B., Hamersky, G. R., Jacob, F., Zhong, C., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.032 · Cited by 2,127
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications
Fabbrini, E., Sullivan, S., & Klein, S. (2010) · Hepatology · doi:10.1002/hep.23280 · Cited by 2,100
Research works printed but not linked: 1
- Cui W., 2010, Am. J. Transl. Res., 2, 95
Cited by
Biomedical Applications of Microfluidic Devices: A Review
Gharib, G., Bütün, İ., Muganlı, Z., Kozalak, G., Namlı, İ., Sarraf, S. S., Ahmadi, V. E., Toyran, E., van Wijnen, A. J., & Koşar, A. (2022) · Biosensors · doi:10.3390/bios12111023 · Cited by 215
Microfluidic organoids-on-a-chip: The future of human models
Saorin, G., Caligiuri, I., & Rizzolio, F. (2023) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2022.10.001 · Cited by 196
HiPSC-derived multi-organoids-on-chip system for safety assessment of antidepressant drugs
Yin, F., Zhang, X., Wang, L., Wang, Y., Zhu, Y., Li, Z., Tao, T., Chen, W., Yu, H., & Qin, J. (2021) · Lab on a Chip · doi:10.1039/d0lc00921k · Cited by 139
Human organoids-on-chips for biomedical research and applications
Wang, H., Ning, X., Zhao, F. H., Zhao, H., & Li, D. (2024) · Theranostics · doi:10.7150/thno.90492 · Cited by 158
Fernandez-Checa, J. C., Bagnaninchi, P., Ye, H., Sancho-Bru, P., Falcon-Perez, J. M., Royo, F., Garcia-Ruiz, C., Konu, O., Miranda, J., Lunov, O., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.06.021 · Cited by 126
Papamichail, L., Koch, L. S., Veerman, D., Broersen, K., & van der Meer, A. D. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1515340 · Cited by 120
Neuropathogenesis-on-chips for neurodegenerative diseases
Amartumur, S., Nguyen, H. M., Huynh, T., Kim, T. S., Woo, R., Oh, E., Kim, K. K., Lee, L. P., & Heo, C. (2024) · Nature Communications · doi:10.1038/s41467-024-46554-8 · Cited by 143
Breakthroughs and Applications of Organ-on-a-Chip Technology
Koyilot, M. C., Natarajan, P., Hunt, C. R., Sivarajkumar, S., Roy, R., Joglekar, S. S., Pandita, S., Tong, C. W.-C., Marakkar, S., Subramanian, L., et al. (2022) · Cells · doi:10.3390/cells11111828 · Cited by 117
Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies
Fang, T., Wang, H., Pan, X., Little, P. J., Xu, S., & Weng, J. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.65044 · Cited by 114
3d organ-on-a-chip: the convergence of microphysiological systems and organoids
Baptista, L. S., Porrini, C., Kronemberger, G. S., Kelly, D. J., & Perrault, C. M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1043117 · Cited by 90
Microfluidic-Based Oxygen (O2) Sensors for On-Chip Monitoring of Cell, Tissue and Organ Metabolism
Azimzadeh, M., Khashayar, P., Amereh, M., Tasnim, N., Hoorfar, M., & Akbari, M. (2021) · Biosensors · doi:10.3390/bios12010006 · Cited by 97
Microfluidic Organ-on-a-Chip Devices for Liver Disease Modeling In Vitro
Kanabekova, P., Kadyrova, A., & Kulsharova, G. (2022) · Micromachines · doi:10.3390/mi13030428 · Cited by 70
In Vitro Models for the Study of Liver Biology and Diseases: Advances and Limitations
Kaur, S., Kidambi, S., Ortega-Ribera, M., Thuy, L. T. T., Nieto, N., Cogger, V. C., Xie, W.-F., Tacke, F., & Gracia-Sancho, J. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.11.008 · Cited by 65
Advances in Microfluidic Technologies in Organoid Research
Liu, H., Gan, Z., Qin, X., Wang, Y., & Qin, J. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202302686 · Cited by 76
Chen, L., Wei, X., Gu, D., Xu, Y., & Zhou, H. (2023) · Cancer Letters · doi:10.1016/j.canlet.2022.216048 · Cited by 61
Human liver organoids: From generation to applications
Afonso, M. B., Marques, V., van Mil, S. W. C., & Rodrigues, C. M. P. (2024) · Hepatology · doi:10.1097/hep.0000000000000343 · Cited by 61
Strategies to overcome the limitations of current organoid technology - engineered organoids
Fan, X., Hou, K., Liu, G., Shi, R., Wang, W., & Liang, G. (2025) · Journal of Tissue Engineering · doi:10.1177/20417314251319475 · Cited by 78
Liver-on-a-chip devices: the pros and cons of complexity
Dalsbecker, P., Adiels, C. B., & Goksör, M. (2022) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00346.2021 · Cited by 64
Advances in human organoids-on-chips in biomedical research
Wang, Y., & Qin, J. (2023) · Life Medicine · doi:10.1093/lifemedi/lnad007 · Cited by 61
Multi-organ-on-a-chip for pharmacokinetics and toxicokinetic study of drugs
Sung, J. H. (2021) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1908996 · Cited by 58
From organoids to organoids-on-a-chip: Current applications and challenges in biomedical research
Liu, K., Chen, X., Fan, Z., Ren, F., Liu, J., & Hu, B. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003535 · Cited by 61
Fanizza, F., Campanile, M., Forloni, G., Giordano, C., & Albani, D. (2022) · Journal of Tissue Engineering · doi:10.1177/20417314221095339 · Cited by 58
Bronsard, J., Savary, C. C., Massart, J., Viel, R., Moutaux, L., Catheline, D., Rioux, V., Clément, B., Corlu, A., Fromenty, B., et al. (2023) · Toxicology in Vitro · doi:10.1016/j.tiv.2023.105728 · Cited by 55
State-of-the-art liver disease research using liver-on-a-chip
Deguchi, S., & Takayama, K. (2022) · Inflammation and Regeneration · doi:10.1186/s41232-022-00248-0 · Cited by 46
Recent advances in organoid engineering: A comprehensive review
Unagolla, J. M., & Jayasuriya, A. C. (2022) · Applied Materials Today · doi:10.1016/j.apmt.2022.101582 · Cited by 51
Qi, L., Gröger, M., Sharma, A., Goswami, I., Chen, E., Zhong, F., Ram, A., Healy, K. E., Hsiao, E. C., Willenbring, H., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52258-w · Cited by 54
From Single- to Multi-organ-on-a-Chip System for Studying Metabolic Diseases
Jang, M., & Kim, H. N. (2023) · BioChip Journal · doi:10.1007/s13206-023-00098-z · Cited by 45
Cancer-on-chip: a 3D model for the study of the tumor microenvironment
Cauli, E., Polidoro, M. A., Marzorati, S., Bernardi, C., Rasponi, M., & Lleò, A. (2023) · Journal of Biological Engineering · doi:10.1186/s13036-023-00372-6 · Cited by 52
Examining the gut-liver axis in liver cancer using organoid models
Shek, D., Chen, D., Read, S. A., & Ahlenstiel, G. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.04.008 · Cited by 40
Recent advances in liver‐on‐chips: Design, fabrication, and applications
Qiu, L., Kong, B., Kong, T., & Wang, H. (2023) · Smart Medicine · doi:10.1002/smmd.20220010 · Cited by 44
Construction of in vitro liver-on-a-chip models and application progress
Liu, J., Du, Y., Xiao, X., Tan, D., He, Y., & Qin, L. (2024) · BioMedical Engineering OnLine · doi:10.1186/s12938-024-01226-y · Cited by 43
Advances in the Model Structure of In Vitro Vascularized Organ-on-a-Chip
Yin, H., Wang, Y., Liu, N., Zhong, S., Li, L., Zhang, Q., Liu, Z., & Yue, T. (2024) · Cyborg and Bionic Systems · doi:10.34133/cbsystems.0107 · Cited by 43
Recent progress of microfluidic technology for pharmaceutical analysis
Jia, X., Yang, X., Luo, G., & Liang, Q. (2021) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2021.114534 · Cited by 39
Role of Intestinal Microbes in Chronic Liver Diseases
Xu, M., Luo, K., Li, J., Li, Y., Zhang, Y., Yuan, Z., Xu, Q., & Wu, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012661 · Cited by 41
Liver Regeneration and Immunity: A Tale to Tell
Di-Iacovo, N., Pieroni, S., Piobbico, D., Castelli, M., Scopetti, D., Ferracchiato, S., Fazia, M. A. D., & Servillo, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021176 · Cited by 47
A decade of liver organoids: Advances in disease modeling
Liu, Y., Sheng, J.-Y., Yang, C.-F., Ding, J., & Chan, Y.-S. (2023) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0428 · Cited by 30
Engineering organoids-on-chips for drug testing and evaluation
Wang, H., Zhu, W., Xu, C., Su, W., & Li, Z. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156065 · Cited by 32
Yang, J., Zhang, X., Liu, Z., Yang, C., Li, S., Zhou, H., & Gao, Z. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.155882 · Cited by 30
Liver Organoids as an In Vitro Model to Study Primary Liver Cancer
Siervi, S. D., & Turato, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054529 · Cited by 35
Human Motor System‐Based Biohybrid Robot‐On‐a‐Chip for Drug Evaluation of Neurodegenerative Disease
Shin, M., Ha, T., Lim, J., An, J., Beak, G., Choi, J., Melvin, A. A., Yoon, J., & Choi, J. (2023) · Advanced Science · doi:10.1002/advs.202305371 · Cited by 34
Elbadawy, M., Tanabe, K., Yamamoto, H., Ishihara, Y., Mochizuki, M., Abugomaa, A., Yamawaki, H., Kaneda, M., Usui, T., & Sasaki, K. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1243258 · Cited by 27
Liver organoids: updates on generation strategies and biomedical applications
Liu, S., Cheng, C., Zhu, L., Zhao, T., Wang, Z., Yi, X., Yan, F., Wang, X., Li, C., Cui, T., et al. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03865-3 · Cited by 33
Li, Y., Yang, X., Plummer, R., Hayashi, Y., Deng, X.-S., Nie, Y., & Taniguchi, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910471 · Cited by 27
Advancements in MAFLD Modeling with Human Cell and Organoid Models
Wang, S.-X., Yan, J.-S., & Chan, Y.-S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911850 · Cited by 22
“demonstrated the feasibility of growing PSC-derived liver organoids in the microfluidic system, highlighting the potential of integrating different approaches for creating MAFLD liver models [51].”
BackgroundLiver Organoids, Novel and Promising Modalities for Exploring and Repairing Liver Injury
He, C., Lu, D., Lin, Z., Chen, H. H., Li, H., Yang, X., Yang, M., Wang, K., Wei, X., Zheng, S., et al. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10456-3 · Cited by 25
Xia, M., Varmazyad, M., Plá-Palacín, I., Gavlock, D. C., DeBiasio, R., LaRocca, G. M., Reese, C. E., Florentino, R. M., Faccioli, L. A. P., Brown, J. A., et al. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1423936 · Cited by 25
Engineered Hydrogels for Organoid Models of Human Nonalcoholic Fatty Liver Disease
Liu, Y., Gilchrist, A. E., Johansson, P. K., Guan, Y., Deras, J. D., Liu, Y., Ceva, S., Huang, M. S., Navarro, R. S., Enejder, A. M. K., et al. (2025) · Advanced Science · doi:10.1002/advs.202417332 · Cited by 29
Engineered Platforms for Maturing Pluripotent Stem Cell–Derived Liver Cells for Disease Modeling
Yuan, Y., Cotton, K., Samarasekera, D. N., & Khetani, S. R. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.01.013 · Cited by 26
Advances in organoid-on-a-chip for recapitulation of human physiological events
Park, B. J., Park, J., Han, S., Kwon, T., Sung, J. Y., Kim, J., Safarkhani, M., Min, K.-H., Lee, E.-H., Kang, S., et al. (2025) · Materials Today · doi:10.1016/j.mattod.2025.02.002 · Cited by 23
Advances in liver organoids: model systems for liver disease
Lee, J., Mun, S. J., Shin, Y., Lee, S., & Son, M. J. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01390-6 · Cited by 22
Emerging biotechnologies for engineering liver organoids
Zhao, J., Zhi, Y., Ren, H., Wang, J., & Zhao, Y. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.11.002 · Cited by 34
Pelechá-Salvador, M., Villanueva-Bádenas, E., Timor-López, E., Donato, M. T., & Tolosa, L. (2021) · Antioxidants · doi:10.3390/antiox11010086 · Cited by 19
Latest impact of engineered human liver platforms on drug development
Monckton, C. P., Brown, G. E., & Khetani, S. R. (2021) · APL Bioengineering · doi:10.1063/5.0051765 · Cited by 18
Baptista, L. S., Silva, K. R., Jobeili, L., Guillot, L., & Sigaudo‐Roussel, D. (2023) · Cells · doi:10.3390/cells12121583 · Cited by 21
Ex Vivo Tools and Models in MASLD Research
Velliou, R.-I., Giannousi, E., Ralliou, C., Kassi, E., & Chatzigeorgiou, A. (2024) · Cells · doi:10.3390/cells13221827 · Cited by 15
“Following the liver-organoids-on-chip formation, the culture medium was supplemented with FFAs for up to 7 days [32].”
InfluentialYu, P., Liu, B., Dong, C., & Chang, Y. (2025) · Cells · doi:10.3390/cells14080619 · Cited by 20
Progress, application and challenges of liver organoids
Sang, C., Lin, J., Ji, S., & Gao, Q. (2024) · Clinical Cancer Bulletin · doi:10.1007/s44272-024-00012-0 · Cited by 16
Fast formation and maturation enhancement of human liver organoids using a liver-organoid-on-a-chip
Byeon, J. H., Jung, D. J., Han, H.-J., Son, W.-C., & Jeong, G. S. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1452485 · Cited by 15
“Furthermore, the organoid could recapitulate several liver diseases, including fatty liver disease, cirrhosis, and monogenic metabolic diseases (Guan et al., 2017; Wang et al., 2020; Guan et al., 2021).”
Three-Dimensional Organoids as a Model to Study Nonalcoholic Fatty Liver Disease
Park, Y., Thadasina, D., Bolujo, I., Isidan, A., Cross-Najafi, A. A., Lopez, K., Li, P., Dahlem, A. M., Kennedy, L. L., Sato, K., et al. (2022) · Seminars in Liver Disease · doi:10.1055/a-1934-5588 · Cited by 15
Microfluidic Techniques for Next‐Generation Organoid Systems
Gong, J., Li, M., Kang, J., Yin, Z., Cha, Z., Yang, J., & Xu, H. (2022) · Advanced Materials Interfaces · doi:10.1002/admi.202200846 · Cited by 17
Standard: human liver-on-a-chip
Liu, H., Zhang, X., Wang, Y., Zhang, M., Wang, P., Shang, J., Li, Z., Gong, L., Xie, X., Liu, D., et al. (2025) · Cell Regeneration · doi:10.1186/s13619-025-00226-0 · Cited by 12
Ghosh, A., Sanyal, A., Kumari, M., Mukerjee, S., Kaity, S., & Roy, S. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb01170a · Cited by 11
A proof-of-concept study poised to remodel the drug development process
Nahle, Z. A. (2022) · Frontiers in Medical Technology · doi:10.3389/fmedt.2022.1053588 · Cited by 12
Revolutionizing renal research: The future of kidney-on-a-chip in biotechnology
Nishimura, Y. (2024) · Regenerative Therapy · doi:10.1016/j.reth.2024.06.006 · Cited by 15
Youhanna, S., Taebnia, N., Liang, Y., Cheng, N., Wang, Y., Michel, M., & Lauschke, V. M. (2025) · Advanced Biology · doi:10.1002/adbi.202500337 · Cited by 9
Self-citationGut-on-chip and liver-on-chip platforms for pathophysiological modeling
Coricciati, C., Mello, E., Luca, E. D., Gigli, G., Rainer, A., & Mozetic, P. (2025) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2025.100601 · Cited by 11
Primary liver cancer organoids and their application to research and therapy
Zhu, X., Trehan, R., & Xie, C. (2024) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2024.06.002 · Cited by 10
Zhang, R., Guo, T., Ji, L., Yin, Y., Feng, S., Lu, W., Zhang, F., Zhu, M., Liu, S., Jiang, J., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.716339 · Cited by 10
Mice Hepatic Organoids for Modeling Nonalcoholic Fatty Liver Disease and Drug Response
Zhou, Z., Zheng, X., Xie, M., Lin, Z., Du, F., Shi, X., & Li, R. (2024) · Stem Cells and Development · doi:10.1089/scd.2024.0067 · Cited by 11
In vitro liver models for toxicological research
Fukunaga, I., & Takebe, T. (2025) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2025.101478 · Cited by 8
A human liver organoids-on-chip for the assessment of drug-induced liver injury
Chen, X., 鲍方, Liu, J., Wang, Y., Tao, T., Zhang, G., & Qin, J. (2026) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-025-01074-z · Cited by 12
Engineering-inspired approaches to study β-cell function and diabetes
Lewis, P. L., & Wells, J. M. (2021) · Stem Cells · doi:10.1002/stem.3340 · Cited by 8
Advancing fatty liver research in dairy cows: Development of a bovine liver organoid model
Lei, Q., Fan, M., Lin, X., Cai, Z., Li, H., Wang, H., Wang, J., Yin, R., Nan, S., Abouelfetouh, M. M., et al. (2025) · Journal of Dairy Science · doi:10.3168/jds.2025-26256 · Cited by 8
Engineering liver organoids-on-a-chip
Zhu, J., Dressman, A. S., Gall, K., & Park, S. E. (2026) · Frontiers in Lab on a Chip Technologies · doi:10.3389/frlct.2025.1719128 · Cited by 9
Liu, M., Ma, Y., Cheang, W. S., Su, Z., & Xu, S. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.04.011 · Cited by 11
Goswami, Y., Baghel, A., Sharma, G., Sharma, P. K., Biswas, S., Yadav, R., Garg, P. K., Shalimar, S., & Tandon, R. (2024) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2024.102463 · Cited by 9
Chen, Q., Li, C., Ding, W., & Kong, D. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202503273 · Cited by 7
Ginsenoside Rb1 improves human nonalcoholic fatty liver disease with liver organoids-on-a-chip
Wang, H., Zhu, Y., Shi, P., Li, X., Bu, Q., Li, Y., You, X., & Zhao, G. (2024) · Engineered Regeneration · doi:10.1016/j.engreg.2024.06.002 · Cited by 8
Huang, Q., Liang, Z., Li, Q., Wang, K. Y., Zhu, S., Xiao, W., & Zhou, L. M. (2026) · Antioxidants · doi:10.3390/antiox15020177 · Cited by 4
Bridging Toxicological Silos with Organoids: A Systems Approach to Human-Relevant Risk Assessment
Zhao, N., Deng, X., Dong, R., & Zhao, Y. (2026) · Environmental Science & Technology · doi:10.1021/acs.est.5c14491 · Cited by 3
Comparison and Characteristics of MASLD Mouse Models
Wei, L., 高春辰, & Qin, H. (2026) · Biomedicines · doi:10.3390/biomedicines14040895 · Cited by 4
NAFLD and AATD Are Two Diseases with Unbalanced Lipid Metabolism: Similarities and Differences
Pérez-Luz, S., Matamala, N., Gómez‐Mariano, G., Janciauskiene, S. M., & Martínez–Delgado, B. (2023) · Biomedicines · doi:10.3390/biomedicines11071961 · Cited by 3
You, X., Li, X., Wang, H., & Zhao, G. (2025) · Cell Proliferation · doi:10.1111/cpr.70118 · Cited by 6
Miniaturized Liver Disease Mimics to Gain Insights into MMP Expression during Disease Progression
Rainu, S. K., & Singh, N. (2024) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.4c01449 · Cited by 3
Ju, R., Tian, S., Shang, Y., Ma, S., Zhang, M., Liu, J., Sun, K., Cui, L., Zhou, X., & Han, Y. (2024) · Materials Advances · doi:10.1039/d4ma00373j · Cited by 4
Advances in Bone-on-a-Chips for In Vitro Modeling of Bone Physiology and Pathology
Cheng, X., Lu, M., Ma, M., Zhou, S., Xu, J., Li, Y., & Lu, H. (2026) · Biomedicines · doi:10.3390/biomedicines14030710 · Cited by 2
Air-blood barrier (ABB) on a chip
Fu, A., Chang, M., Zhu, H., Liu, H., Wu, D., & Zeng, H. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.116919 · Cited by 2
Nguyen, K. M., Che, Q. T., Nguyen, Q. H., Gwon, K., Gonzalez‐Suarez, A. M., Stybayeva, G., Huebert, R. C., Peterson, Q. P., & Revzin, A. (2025) · Biomaterials Science · doi:10.1039/d5bm00696a · Cited by 1
Current advances and prospects in biomaterials-guided tools for liver organoids research
Ahmed, S. G., Alshehri, E., Nazneen, S., Attia, F., Obeid, D. A., Almuzaini, H., Alzahrani, A., Salma, J., Fujitsuka, I., Assiri, A. M., et al. (2025) · Engineered Regeneration · doi:10.1016/j.engreg.2025.07.004 · Cited by 4
Han, Y.-Q., Xu, Y., Xiang, Z., Xu, Q.-F., Gao, F., Yan, M.-N., & Wu, J. (2026) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2026.01.008 · Cited by 2
Lee, K. L., Wee, H. S.-A., Teng, Z. Y., Tay, H. M., Chee, Y. J., Tan, E. X. X., Dan, Y. Y., Muthiah, M. D., Dalan, R., Hou, H. W., et al. (2026) · Stem Cell Research & Therapy · doi:10.1186/s13287-026-05130-1 · Cited by 1
Vascularization of organoids in microfluidic chips
Chowdary, P., Yadav, D. N., Pogu, S. V., & Rengan, A. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13782-2.00016-4 · Cited by 1
The liver organoid's past, present and future: a personalized medicine strategy
Abady, M. M., Zahran, I. A., & Elmokhtar, Y. M. (2024) · International Journal of Health Sciences · doi:10.53730/ijhs.v8ns1.14980 · Cited by 2
Yaqing, W. A. N. G., Tao, T., & Qin, J. (2022) · Scientia Sinica Vitae · doi:10.1360/ssv-2022-0027 · Cited by 2
Insight to Biofabrication of Liver Microtissues for Disease Modeling: Challenges and Opportunities
Dortaj, H., Azarpira, N., & Pakbaz, S. (2023) · Current Stem Cell Research & Therapy · doi:10.2174/011574888x257744231009071810
Baranowska, P., Flont, M., Żuchowska, A., Brzózka, Z., & Jastrzębska, E. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15978-7.00048-5
Díez-Martín, E., Astigarraga, E., & Barreda‐Gómez, G. (2024) · Springer eBooks · doi:10.1007/978-981-97-5473-1_7
Organoids for Obesity-related Diseases: Disease Models and Drug Screening
Xie, J., Zhou, K., Zhang, H., Jiang, Z., & Fang, J. (2025) · Current Stem Cell Research & Therapy · doi:10.2174/011574888x357011250406044043
Yang, J., Ren, L., Chen, Y., Zhou, Q., Hu, H., Bian, R., Qiu, P., & Lou, D. (2025) · Materials Today Communications · doi:10.1016/j.mtcomm.2025.114033 · Cited by 1
Li, K., Zhang, Z., Chen, R., Wu, S., Yang, N., Chen, J., Zhao, H., Wang, P., 尹云玫, Xiao, M., et al. (2026) · Antioxidants · doi:10.3390/antiox15020189
Metadata
- Authors
- Wang, Y., Wang, H., Deng, P., Tao, T., Liu, H., Wu, S., Chen, W., & Qin, J.
- Affiliations
- Dalian Institute of Chemical Physics (CN)
- Dalian University of Technology (CN)
- Corresponding author
- Qin, Jianhua
- Venue
- ACS Biomaterials Science & Engineering
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-09-16
- Volume
- 6
- Issue
- 10
- Pages
- 5734-5743
- ISSN
- 2373-9878 (ISSN-L)
- OpenAlex
- W3087345910
- Cited by
- 109
- References
- 49
- Citations by year
- 2026: 19 · 2025: 18 · 2024: 24 · 2023: 18 · 2022: 19 · 2021: 10 · 2020: 1
- FWCI
- 8.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- ACS Biomaterials Science & Engineering (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Science and Technology of the People's Republic of China (2018ZX09201017-001-001)
- Dalian Institute of Chemical Physics (DICP I201934)
- National Natural Science Foundation of China (31671038, 81703470, 81803492)
- Chinese Academy of Sciences (XDA16020900, XDB29050301, XDB32030200)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- non-alcoholic fatty liver disease, liver organoids, organ-on-a-chip, induced pluripotent stem cells, free fatty acids, lipid droplet formation, triglyceride accumulation, lipid metabolism, reactive oxygen species, inflammation, liver fibrosis, steatosis, disease modeling
- MeSH terms
- Humans, Organoids, Lipid Metabolism, Lab-On-A-Chip Devices, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.